New hope for dialysis patients battling dangerous mineral buildup
NCT ID NCT06745531
First seen Nov 17, 2025 · Last updated Apr 20, 2026 · Updated 25 times
Summary
This study tested a new drug called TS-172 to see if it could safely lower high phosphorus levels in people on kidney dialysis. High phosphorus is a common and serious problem for dialysis patients. Researchers compared the drug to a placebo (a dummy pill) in 101 patients to see which was better at getting phosphorus levels into a safe range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPHOSPHATEMIA PATIENTS ON HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taisho Pharmaceutical Co., Ltd selected site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.